stated objectives of INSITE (see appendix B). Each table contains highlights from: (i) published and unpublished research on INSITE, data on use provided by ( VCH ), and three pieces of additional research requested by the EAC ; (ii) research on the Sydney, Australia SIS ; and (iii) research on other SISs in other countries. Over 8,000 people have visited INSITE to inject drugs. Eighteen percent or 1506 of these 8,000 people account for 86% of the overall visits to INSITE. Less than 10% used INSITE for all injections. The median number of visits is approximately eight. An average of more than 600 visits a day shows that INSITE operates near capacity. Approximately 80% of the 600 daily visits are for injecting, the remaining 20% for other support services such as counseling. Based upon two surveys of a sample of approximately 1,000 users, the following key user characteristics have been identified: have been injecting drugs for an average of 15 years; majority (51%) inject heroin and 32% cocaine; 87% are infected with Hepatitis C virus ( HCV ) and 17% with human immunodeficiency virus ( HIV ); 18% are aboriginal; 20% are homeless and many more live in single resident rooms; 80% have been incarcerated; 38% are involved in the sex trade; 21% were using methadone; and 59% reported a non-fatal overdose in their lifetime. The injections at INSITE account for less than 5% of injections in the DTE . This limits the likelihood of significant direct impact from INSITE